Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Impact
The resolution highlights the growing concern among lawmakers about the implications of the legal challenges against mifepristone, a medication approved by the FDA for medical termination of pregnancy. By encouraging congressional action, SCR47 aims to ensure that access to safe and effective abortion methods is preserved amidst a backdrop of tightening restrictions in certain states. The bill stresses the critical nature of maintaining access to this medication, especially when many individuals are struggling to find safe abortion care services.
Summary
SCR47 is a Senate Concurrent Resolution introduced in Hawaii's 32nd Legislature in 2023. It urges the members of Hawaii's congressional delegation to closely monitor the ongoing case of The Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, which threatens to restrict access to medication abortions via the drug mifepristone. This resolution is a direct response to the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, which overturned nearly fifty years of established federal precedent on reproductive rights and has led to varying degrees of restriction or outright bans on abortion across different states.
Contention
Notable points of contention arise from the potential nationwide implications of the Alliance case's ruling, which could not only ban mifepristone but also prevent healthcare providers from offering it in states where abortion remains legal. This would severely limit reproductive healthcare options for individuals within those jurisdictions. As states grapple with diverging regulations on abortion access post-Dobbs, the resolution serves as a clarion call for bolstering state and federal efforts to protect women's health rights and ensure that safe abortion options remain accessible.
Same As
Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Urging The Governor To Ensure That Relevant State Agencies, Including The Department Of Health And Department Of Human Services, Collaborate To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Members Of Hawaii's Congressional Delegation And The Biden Administration To Call For An Immediate, Permanent Bilateral Ceasefire In Gaza And The Return Of All Hostages, And To Continue Negotiations For Lasting Peace In The Region.
Urging The Governor, Department Of Human Services, And Department Of Health To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Members Of Hawaii's Congressional Delegation To Introduce Legislation To Expand The National Flood Insurance Program To Include Lava And Earthquake Insurance.
Urging The Governor, Department Of Human Services, And Department Of Health To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Governor To Ensure That Relevant State Agencies, Including The Department Of Health And Department Of Human Services, Collaborate To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Members Of Hawaii's Congressional Delegation To Introduce Legislation To Expand The National Flood Insurance Program To Include Lava Insurance.
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.